In one paragraphArticle in Cancer biology & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Jiawei LiDepartment of Precision Biomedical Key Laboratory, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Shandong Provincial Key Medical and Health Laboratory of Precision Medicine for Aging Intervention and Active Health, Liaocheng, People's Republic of China.ORCID 0009-0004-8760-5965 Min LiDepartment of Precision Biomedical Key Laboratory, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Shandong Provincial Key Medical and Health Laboratory of Precision Medicine for Aging Intervention and Active Health, Liaocheng, People's Republic of China.
Jianran GuoDepartment of Precision Biomedical Key Laboratory, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Shandong Provincial Key Medical and Health Laboratory of Precision Medicine for Aging Intervention and Active Health, Liaocheng, People's Republic of China.
Dongbao LiDepartment of Precision Biomedical Key Laboratory, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Shandong Provincial Key Medical and Health Laboratory of Precision Medicine for Aging Intervention and Active Health, Liaocheng, People's Republic of China.
Yumin YaoLiaocheng Key Laboratory for Precision Diagnosis and Treatment of Malignant Tumors, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Liaocheng, People's Republic of China.
Wei ZhangLiaocheng Key Laboratory for Precision Diagnosis and Treatment of Malignant Tumors, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Liaocheng, People's Republic of China.ORCID 0009-0000-4419-7691 Chuanyou CuiLiaocheng Key Laboratory for Precision Diagnosis and Treatment of Malignant Tumors, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Liaocheng, People's Republic of China.ORCID 0009-0007-4806-0706 Bo FuDepartment of Precision Biomedical Key Laboratory, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Shandong Provincial Key Medical and Health Laboratory of Precision Medicine for Aging Intervention and Active Health, Liaocheng, People's Republic of China.ORCID 0000-0002-6584-391X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
backgroundDue to the heterogeneity of breast cancer (BRCA) and the limited therapeutic efficacy in specific molecular subtypes, identifying new and effective therapeutic targets remains an urgent clinical need. The transcription factor
methods
results
conclusionIn BRCA,
Indexed as
Breast NeoplasmsFerroptosisMethyltransferasesTranscription FactorsAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionDNA-Binding ProteinsFemaleGene Expression Regulation, NeoplasticHumansMiceRNA MethylationDNA-Binding ProteinsMethyltransferasesNSUN2 protein, humanSALL2 protein, humanTranscription Factorsbreast cancerferroptosism5C methylationNSUN2SALL2
Identifiers
PMID42377119
PMCPMC13327353
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390